| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |